Implantation or Injectable Dosage Form New Animal Drugs; Lufenuron Suspension
other · Food and Drug Administration · Rule · Published 1998-06-01 · 63 FR 29551
Document
Document number
98-14298
Federal Register citation
63 FR 29551
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-06-01
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for subcutaneous use of lufenuron suspension in cats for control of flea populations.